ZBTB20 Protein and Liver Cancer Prognosis
Author Information
Author(s): Wang Qing, Tan Ye-xiong, Ren Yi-bin, Dong Li-wei, Xie Zhi-fang, Tang Liang, Cao Dan, Zhang Wei-ping, Hu He-ping, Wang Hong-yang
Primary Institution: Eastern Hepatobiliary Surgery Institute, the Second Military Medical University
Hypothesis
The study aims to determine the potential clinical implications of ZBTB20 in hepatocellular carcinoma (HCC).
Conclusion
ZBTB20 expression is increased in HCC and is associated with poor prognosis in patients.
Supporting Evidence
- ZBTB20 expression was significantly higher in HCC tissues compared to non-tumor tissues.
- Higher ZBTB20 expression was associated with increased rates of recurrence and metastasis.
- ZBTB20 overexpression was identified as an independent prognostic factor for HCC.
Takeaway
This study found that a protein called ZBTB20 is found in higher amounts in liver cancer, and having more of it means patients might not do as well.
Methodology
Quantitative real-time RT-PCR and Western blot analyses were used to detect ZBTB20 expression in HCC tissues.
Participant Demographics
The study included 152 patients with HCC, with a majority being male (118 out of 152).
Statistical Information
P-Value
0.003
Confidence Interval
95%CI, 1.06 months to 34.94 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website